Your Era publishes one tracked compound as a floor per month and prints the same figure in both places it appears — and publishes almost nothing else a reader can check before an intake.
What Your Era charges
NAD+: $170 — from — the product card and the catalog row both print this as a floor per month
Your Era is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A one-page catalogue and very little else
This seller has no sitemap, and the two documents a reader would normally check both return not-found when rendered.
The whole readable surface is a home page whose products are anchors on that page rather than pages of their own.
The one other document is a refund policy, so there is no terms page and no answers page to consult.
The nonsense-path control on this host returns a not-found code and a single short sentence.
The figure appears twice and agrees with itself
The cellular-energy product carries the same figure on its card and again in the catalogue row beneath it.
That consistency is worth recording because another seller read in the same run prints two different starting figures for one product.
Both instances introduce it with the word from, so it is the bottom of a range rather than a settled rate.
It is stored as a floor for exactly that reason, so nothing downstream can present it as what a month costs.
Three other figures on the same page, none of them peptides
The catalogue prices two weight-loss lines and a microdosing protocol alongside the compound this site tracks.
Each of those was read in its own card and none is recorded anywhere on this row.
A parser matching a figure to the nearest compound name on this page would have had four candidates and no way to choose.
Reading each card as its own unit is what keeps the peptide figure separate from the three that are not.
Nothing to check before the intake
The intake lives on a different host and opens with an email gate, and it was not walked.
No dispensing pharmacy is named anywhere on the readable surface, and no state list is published.
No corporate form is published either, so there is no registered company a reader can look up.
No claim about lab work appears at all, so nothing here treats testing as part of the price.
Who it's for
Readers who want a rough starting point before committing time to an intake.
Buyers who want the cellular-energy line priced apart from the weight-loss lines.
Shoppers comparing several treatment categories on one screen.
Anyone checking whether a card figure and a catalogue figure agree.
Who should look elsewhere
Readers who need a price they will actually pay.
Buyers who want a terms page or an answers page to read first.
Shoppers who need the dispensing pharmacy named.
Anyone who needs a state footprint or a registered company name.
Strengths
Prints the same figure on the card and in the catalog row, so the two do not contradict each other
Separates its NAD+ line from its weight-loss lines rather than pricing them as one program
Links a third-party verification listing for its own domain in the footer
Keeps the whole priced catalog on one screen a reader can compare at once
Trade-offs
Publishes no terms page and no FAQ; both addresses return not-found
Names no dispensing pharmacy anywhere on the readable surface
Publishes no state list and no corporate entity
Prices one tracked compound only, as a floor, with no dose or form stated
How we verified this
Read every page cited on this row as rendered text in a real browser, not as served HTML, because several sellers in this pass ship the figure in by script and serve a bare currency sign.
Fired a nonsense-path control at this host in the same run and judged it on the rendered document rather than on its status code or its byte count.
Joined every text node before scanning for a currency sign, so a figure split across nested elements could not read as an absence.
Clicked every collapsed accordion on the pages read, because pharmacy names, state answers and lab conditions hid inside them on most sellers checked this pass.
Read each figure inside its own card or panel rather than by nearness to a compound name, on pages that price weight-loss lines beside peptide lines.
Recorded the seller's own published figure and never divided a multi-month total into a monthly one.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter unless the letter itself named this seller's own domain.
Requested this seller's sitemap, terms page and answers page, and recorded that all three fail rather than assuming they exist.
Compared the card figure with the catalogue figure for the same product and confirmed the two agree.
Stopped at the email gate on the separate intake host and let nothing on this row rest on what lies behind it.
A provider to compare Your Era against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.